Myelodysplastic Syndromes (MDS) Clinical Trials

A listing of Myelodysplastic Syndromes (MDS) medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Connecticut

Hartford Connecticut 06105

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Georgia

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Missouri

Kansas City Missouri 64128

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

St. Louis Missouri 63110

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

New York

Bronx New York 10461

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

North Carolina

Winston-Salem North Carolina 27157

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

North Dakota

Argentina

Ciudad Autonoma Buenos Aires 1425

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Ciudad Autonoma Buenos Aires 1114

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Santa Fe S3000ADL

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Australia

Adelaide South Australia 5000

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Clayton Victoria 3168

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

East Melbourne Victoria 3002

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Kogarah New South Wales 2217

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Belgium

Brasschaat 2930

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Brugge 8000

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Leuven 3000

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Lodelinsart 6042

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Turnhout 2300

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Canada

Quebec Quebec G1J 1Z4

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Czech Republic

Brno 625 00

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Ostrava 708 52

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Prague 150-06

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Praha 10 100 34

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Praha 2 128 08

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Denmark

Aarhus 8000 C

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

France

Le Mans 72000

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Germany

Dresden Sachsen 01307

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Duisburg Nordrhein-Westfalen 47166

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Frankfurt 60590

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Hanover 30625

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Jena 07740

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

View More ▼

Muenchen Bayern 81675

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Munster 48129

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Regensburg 93053

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Würzburg 97080

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Myelodysplastic Syndromes (MDS) or Juvenile Myelomonocytic Leukaemias (JMML)

Greece

Patra 26500

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Thessaloniki 54642

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Hong Kong

Chai Wan

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Hong Kong

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Hungary

Debrecen 4012

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Ireland

Dublin 7

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Galway

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

James Street 8

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Limerick

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Tallaght, Dublin 24

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Israel

Jerusalem 91120

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Tel Aviv 64239

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Italy

Firenze Toscana 50134

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia

Genova Liguria 10126

A clinical trial to evaluate treatments using Eltrombopag, Azacitidine and Placebo for patients with Thrombocytopaenia